STUDY SEARCH RESULTS

1 study found for your search request:  8591A-054

A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Vir...
Condition: HIV Infection
Minimum Age: 18, Maximum Age: N/A
Gender: All
Study ID: NCT05766501
Status: Active, not recruiting




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site